Indivior Pharmaceuticals, Inc.
INDV
$36.76
-$1.07-2.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.08% | -39.06% | 39.94% | 34.56% | 13.03% |
| Total Receivables | 4.78% | -11.15% | 0.37% | -13.52% | 5.43% |
| Inventory | -6.75% | -8.38% | -12.92% | -12.87% | 0.00% |
| Prepaid Expenses | -73.21% | 9.68% | 66.67% | 55.56% | 80.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 110.53% | -31.82% | 42.86% | 40.00% | 35.71% |
| Total Current Assets | -24.46% | -21.16% | 15.39% | 10.07% | 10.93% |
|
|
|||||
| Total Current Assets | -24.46% | -21.16% | 15.39% | 10.07% | 10.93% |
| Net Property, Plant & Equipment | 26.95% | 22.30% | 32.76% | 42.06% | 25.89% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -71.43% | -66.67% | -98.94% | -96.76% | -96.93% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.58% | 10.09% | -6.91% | -1.56% | 9.69% |
| Total Assets | -12.95% | -8.74% | -3.28% | -5.41% | -5.37% |
|
|
|||||
| Total Accounts Payable | -23.91% | -23.81% | -18.00% | 8.70% | 15.00% |
| Total Accrued Expenses | -14.53% | 9.65% | 2.88% | 12.06% | 13.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -68.97% | 39.29% | 100.00% | 123.08% | 141.67% |
| Total Finance Division Other Current Liabilities | -65.25% | -63.56% | -18.05% | -35.79% | 24.21% |
| Total Other Current Liabilities | -65.25% | -63.56% | -18.05% | -35.79% | 24.21% |
| Total Current Liabilities | -22.49% | -1.08% | 0.31% | 4.35% | 16.72% |
|
|
|||||
| Total Current Liabilities | -22.49% | -1.08% | 0.31% | 4.35% | 16.72% |
| Long-Term Debt | 56.27% | -7.94% | 29.36% | 31.06% | 32.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -53.33% | -31.25% | -31.43% | -12.12% | -6.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -80.25% | -80.89% | -17.29% | -15.96% | -0.32% |
| Total Liabilities | -19.22% | -21.42% | -0.49% | 3.20% | 15.04% |
|
|
|||||
| Common Stock & APIC | 6.45% | 14.47% | 119.23% | 108.97% | 96.20% |
| Retained Earnings | 31.03% | 45.15% | -132.34% | -134.52% | -132.32% |
| Treasury Stock & Other | 14.71% | 36.96% | 97.57% | 97.58% | 97.43% |
| Total Common Equity | 49.47% | 70.92% | -23.95% | -112.40% | -2,950.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.47% | 70.92% | -23.95% | -112.40% | -2,950.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 49.47% | 70.92% | -23.95% | -112.40% | -2,950.00% |
|
|
|||||